Exact Mass: 181.9980252
Exact Mass Matches: 181.9980252
Found 499 metabolites which its exact mass value is equals to given mass value 181.9980252,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1-Methyluric acid
1-Methyluric acid is one of the three main theophylline metabolites in man. 1-Methyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152, 4039734, 9890610) [HMDB] 1-Methyluric acid is one of the three main theophylline metabolites in man. 1-Methyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline, and theobromine). Methyluric acids can be distinguished from uric acid via simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase, or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 superfamily, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis (PMID:11712316, 15833286, 3506820, 15013152, 4039734, 9890610).
Succimer
Succimer is only found in individuals that have used or taken this drug. It is a mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them. [PubChem]Succimer is a heavy metal chelator. It binds with high specificity to ions of lead in the blood to form a water-soluble complex that is subsequently excreted by the kidneys. Succimer can also chelate mercury, cadmium, and arsenic in this manner. D064449 - Sequestering Agents > D002614 - Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
7-Methyluric acid
7-Methyluric acid is the minor urinary metabolites of caffeine. Caffeine is metabolized mainly in the liver undergoing demethylation and oxidation. [HMDB] 7-Methyluric acid is the minor urinary metabolites of caffeine. Caffeine is metabolized mainly in the liver undergoing demethylation and oxidation.
Methylselenopyruvate
This compound belongs to the family of Alpha Keto-Acids and Derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the adjacent carbon.
9-Methyluric acid
9-Methyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152) [HMDB] 9-Methyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152).
3-Methyluric acid
3-Methyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152) [HMDB] 3-Methyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152).
(Z)-Methyl 3-(methylsulfinyl)-1-propenyl disulfide
(Z)-Methyl 3-(methylsulfinyl)-1-propenyl disulfide is found in onion-family vegetables. (Z)-Methyl 3-(methylsulfinyl)-1-propenyl disulfide is a constituent of Allium sativum (garlic) and Allium ursinum (ramsons) Constituent of Allium sativum (garlic) and Allium ursinum (ramsons). (E)-Methyl 3-(methylsulfinyl)-1-propenyl disulfide is found in garlic and onion-family vegetables.
Dipropyl trisulfide
Dipropyl trisulfide is found in garden onion. Dipropyl trisulfide is a component of onion oil. Dipropyl trisulfide is a flavouring ingredient. Component of onion oil. Flavouring ingredient. Dipropyl trisulfide is found in garden onion and onion-family vegetables.
Ethyl 1-(ethylthio)ethyl disulfide
Ethyl 1-(ethylthio)ethyl disulfide is found in fruits. Ethyl 1-(ethylthio)ethyl disulfide is a constituent of the fruit of Durio zibethinus (durian). Constituent of the fruit of Durio zibethinus (durian). Ethyl 1-(ethylthio)ethyl disulfide is found in fruits.
Ethyl 1-(methylthio)propyl disulfide
Ethyl 1-(methylthio)propyl disulfide is found in onion-family vegetables. Ethyl 1-(methylthio)propyl disulfide is a constituent of shallots (Allium cepa) and Chinese chives (Allium tuberosum). Constituent of shallots (Allium cepa) and Chinese chives (Allium tuberosum). Ethyl 1-(methylthio)propyl disulfide is found in garden onion and onion-family vegetables.
1,1'-Thiobis-1-propanethiol
1,1-Thiobis-1-propanethiol is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]"). It is used as a food additive
1,2-Dinitroglycerin
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Flurothyl
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
6-[Ethoxy(mercapto)methylidene]-1-cyclohexa-2,4-dienone
Diisopropyl trisulfide
Diisopropyl trisulfide is a member of the class of compounds known as organic trisulfides. Organic trisulfides are organosulfur compounds with the general formula RSSSR (R,R=alkyl, aryl). Diisopropyl trisulfide is a garlic and sulfury tasting compound found in garden onion, which makes diisopropyl trisulfide a potential biomarker for the consumption of this food product.
Aethyl-but-2-enyl-dichlor-silan|ethyl-but-2-enyl-dichloro-silane|ethylbutenyldichlorosilane
2-(Buta-1,3-diynyl)-5-(but-3-en-1-ynyl) thiophene|2--5--thiophen|2-butadiynyl-5-but-3-en-1-ynyl-thiophene
1-Methyluric acid
An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by a methyl group at N-1. It is one of the metabolites of caffeine found in human urine.
4-Nitroanthranilic acid
CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3787; ORIGINAL_PRECURSOR_SCAN_NO 3785 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3808; ORIGINAL_PRECURSOR_SCAN_NO 3805 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3790; ORIGINAL_PRECURSOR_SCAN_NO 3785 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3777; ORIGINAL_PRECURSOR_SCAN_NO 3775 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3856; ORIGINAL_PRECURSOR_SCAN_NO 3855 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3797; ORIGINAL_PRECURSOR_SCAN_NO 3793
1,3-DINITROGLYCERIN
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
1,2-DINITROGLYCERIN
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Methyl 3-(methylsulfinyl)-1-propenyl disulfide
2-Chloro-4-(trifluoromethyl)pyrimidine
C5H2ClF3N2 (181.98585980000001)
6-chloro-3,4-dihydro-1H-quinoxalin-2-one
C8H7ClN2O (182.02468819999999)
8-Chloro-6-Methyl-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine
2-CHLORO-4-METHOXY-1H-BENZIMIDAZOLE
C8H7ClN2O (182.02468819999999)
Zinc Acetate
A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(7-Chloro-1H-indazol-4-yl)methanol
C8H7ClN2O (182.02468819999999)
3-Chloro-5-methoxy-1H-pyrrolo[2,3-b]pyridine
C8H7ClN2O (182.02468819999999)
4,5,6,7-Tetrahydro-2-benzothiophene-1-carboxylic acid
3-Chloro-6-(trifluoromethyl)pyridazine
C5H2ClF3N2 (181.98585980000001)
2-Methyl-5-Chloro-6-Benzoxazolamine
C8H7ClN2O (182.02468819999999)
2-Carboxy-3-chloro-5-cyanopyridine, 6-Carboxy-5-chloropyridine-3-carbonitrile, 3-Chloro-5-cyanopicolinic acid
2-Chloro-5-(trifluoromethyl)pyrazine
C5H2ClF3N2 (181.98585980000001)
4,5,6,7-TETRAHYDROBENZO[B]THIOPHENE-3-CARBOXYLIC ACID
1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1,6-dimethyl
6-Chloro-1-methyl-1H-pyrazolo[3,4-b]pyridin-3-amine
3-Chloro-7-methoxy-1H-pyrrolo[3,2-b]pyridine
C8H7ClN2O (182.02468819999999)
7-Chloro-4-methoxy-1H-pyrrolo[2,3-c]pyridine
C8H7ClN2O (182.02468819999999)
2-CHLORO-1H-BENZIMIDAZOLE-6-METHANOL
C8H7ClN2O (182.02468819999999)
4-Chloro-6-(trifluoromethyl)pyrimidine
C5H2ClF3N2 (181.98585980000001)
2-Chloro-5-(trifluoromethyl)pyrimidine
C5H2ClF3N2 (181.98585980000001)
(5-CHLORO-1H-INDAZOL-3-YL)METHANOL
C8H7ClN2O (182.02468819999999)
4-Chloro-2-trifluoromethyl-pyrimidine
C5H2ClF3N2 (181.98585980000001)
3-Fluoro-4-hydroxy-5-nitrobenzonitrile
C7H3FN2O3 (182.01277000000002)
Thieno[2,3-b]pyrazine-2,3-dione, 1,4-dihydro-7-methyl- (9CI)
Zinc 2,4-Pentanedionate Monohydrate
C5H10O3Zn++ (181.99213600000002)
6-Methylimidazo[2,1-b][1,3]thiazole-5-carboxylic acid
2(1H)-Quinoxalinone,7-chloro-3,4-dihydro-
C8H7ClN2O (182.02468819999999)
sodium,2-(5-sulfanylidene-2H-tetrazol-1-yl)acetate
7-Chloro-5-methyl-1H-pyrazolo[4,3-b]pyridin-3-amine
7-Chloro-5-methoxy-1H-pyrrolo[2,3-c]pyridine
C8H7ClN2O (182.02468819999999)
3-Methylimidazo[2,1-b][1,3]thiazole-5-carboxylic acid
5-methylimidazo[2,1-b][1,3]thiazole-6-carboxylic acid
2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridin-5-one
C8H7ClN2O (182.02468819999999)
2-chloro-4-ethoxypyridine-3-carbonitrile
C8H7ClN2O (182.02468819999999)
Dihydroxyacetone phosphate dilithium salt
Dihydroxyacetone phosphate is a member of the class of glycerone phosphates that consists of glycerone bearing a single phospho substituent. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a primary alpha-hydroxy ketone and a member of glycerone phosphates. It is functionally related to a dihydroxyacetone. It is a conjugate acid of a glycerone phosphate(2-).
4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid
(4-Chloro-1H-pyrrolo[2,3-b]pyridin-5-yl)methanol
C8H7ClN2O (182.02468819999999)
5-Chloro-4-methoxy-1H-pyrrolo[2,3-b]pyridine
C8H7ClN2O (182.02468819999999)
3-(Trifluoromethyl)-1,2,4-oxadiazole-5-carboxylic acid
2-Chloro-6-(trifluoromethyl)pyrazine
C5H2ClF3N2 (181.98585980000001)
2-Chloro-3-(trifluoromethyl)pyrazine
C5H2ClF3N2 (181.98585980000001)
5-Chloro-6-methoxy-1H-pyrrolo[2,3-b]pyridine
C8H7ClN2O (182.02468819999999)
2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-methylsulfanyl-1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
2-Chloro-5-methoxy-1H-benzimidazole
C8H7ClN2O (182.02468819999999)
7-Chloro-2,5-dimethyl-[1,2,4]triazolo[1,5-c]pyrimidine
2-Chloro-3-cyano-6-methoxy-4-methyllpyridine
C8H7ClN2O (182.02468819999999)
2-chloro-4,4,5,5-tetramethyl-1,3,2-dioxaphospholane
4-CHLORO-5-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE
C8H7ClN2O (182.02468819999999)
5-(TRIFLUOROMETHYL)DIHYDROPYRIMIDINE-2,4(1H,3H)-DIONE
3-methylsulfanyl-2,4,8,9-tetrazabicyclo[4.3.0]nona-1,3,6-trien-5-one
5-chloro-3,4-dihydro-1H-quinoxalin-2-one
C8H7ClN2O (182.02468819999999)
IMidazo[2,1-b]thiazole-6-carboxylic acid, Methyl ester
2-amino-7-methyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one
3-Chloro-5-(trifluoromethyl)pyridazine
C5H2ClF3N2 (181.98585980000001)
Hexahydro-1,4,5-Oxadiazepine hydrobromideHexahydro-1,4,5-Oxadiazepine hydrobromide
C4H11BrN2O (182.00546959999997)
2-AMINO-4-CHLORO-3,5,6-TRIFLUOROPYRIDINE
C5H2ClF3N2 (181.98585980000001)
5-CHLORO-2-HYDROXY-4,6-DIMETHYLNICOTINONITRILE
C8H7ClN2O (182.02468819999999)
Fosfomycin sodium
Fosfomycin (MK-0955) sodium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis. Fosfomycin sodium shows both in vivo and in vitro activity against a wide range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria[1][2].
7-Chloro-1,3-dimethyl-1H-pyrazolo[4,3-d]pyrimidine
1H-INDAZOLE-3-CARBOXALDEHYDE HYDROCHLORIDE
C8H7ClN2O (182.02468819999999)
6-carbamoyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid
3H-Diazirine-3,3-dicarboxylic acid monomethyl ester potassium salt
5-Chloro-2-(trifluoromethyl)pyrimidine
C5H2ClF3N2 (181.98585980000001)
1H-Benzimidazole-2-methanol,6-chloro-
C8H7ClN2O (182.02468819999999)
6-chloro-imidazo[1,2-a]pyridine-2-Methanol
C8H7ClN2O (182.02468819999999)
5-AMINOPYRIDIN-3-OL DIHYDROCHLORIDE
C5H8Cl2N2O (182.00136579999997)
methyl 2,2-dichloro-1-methylcyclopropane-1-carboxylate
6-chloro-[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde
C6H3ClN4O (181.99953779999998)
Ethanone, 1-(1,3-benzodioxol-5-yl)-2-fluoro- (9CI)
3-chloro-2,5,6-trifluoropyridin-4-amine
C5H2ClF3N2 (181.98585980000001)
3-AMINO-6-METHYL-THIAZOLO[3,2-B][1,2,4]TRIAZIN-7-ONE
2-(methylsulfanyl)-1H,4H-pyrazolo[1,5-a][1,3,5]triazin-4-one
6-CHLOROPYRIMIDO[5,4-D]PYRIMIDIN-4(3H)-ONE
C6H3ClN4O (181.99953779999998)
6-OXO-1,6-DIHYDRO-PYRAZINE-2,3-DICARBOXYLIC ACID DIAMIDE
Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione,5-methyl-
6-methylimidazo[2,1-b][1,3]thiazole-3-carboxylic acid
7-Chloro-2,3-dihydro-1,8-naphthyridin-4(1H)-one
C8H7ClN2O (182.02468819999999)
5-Nitrosalicylate
A monohydroxybenzoate that is obtained by removal of a proton from the carboxylic acid group of 5-nitrosalicylic acid.
Flurothyl
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylate
2-Amino-4-phosphonobutanoate
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018690 - Excitatory Amino Acid Agonists D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
4-Methoxy-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate
Seleno-L-homocysteine
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(4R)-4-azanyl-4,5-dihydro-1,2-oxazol-3-yl] dihydrogen phosphate
2-(2-Methylidenecyclopropyl)-3-oxobutanedioic acid
Phosphoric acid (E)-3-methyl-4-hydroxy-2-butenyl ester
Se-methylselenocysteinate
An alpha-amino acid anion having methylselanylmethyl as the side-chain.
Se-methyl-L-selenocysteinate
An L-alpha-amino acid anion having methylselanylmethyl as the side-chain.
Se-methyl-D-selenocysteinate
A D-alpha-amino acid anion having methylselanylmethyl as the side-chain.
(R)-2-hydroxy-4-(hydroxymethylphosphinyl)butyric acid
Succimer
D064449 - Sequestering Agents > D002614 - Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
(Z)-Methyl 3-(methylsulfinyl)-1-propenyl disulfide
5-Nitroanthranilic acid
An aminobenzoic acid in which the the amino group is ortho- to the carboxylic acid group, and which is substituted para- to the amino group by a nitro group.
4-Pyridoxate
A pyridoxate that is the conjugate base of 4-pyridoxic acid, obtained by deprotonation of the carboxy group.
5-Pyridoxate
A pyridoxate that is the conjugate base of 5-pyridoxic acid, obtained by deprotonation of the carboxy group.
(2S)-2-hydroxy-3-oxobutyl phosphate(2-)
The dianion resulting from the removal of the two acidic protons from the phosphate group of (2S)-2-hydroxy-3-oxobutyl phosphate.
2-(1,3-butadiynyl)-5-(3-buten-1-ynyl)thiophene
{"Ingredient_id": "HBIN003528","Ingredient_name": "2-(1,3-butadiynyl)-5-(3-buten-1-ynyl)thiophene","Alias": "NA","Ingredient_formula": "C12H6S","Ingredient_Smile": "NA","Ingredient_weight": "182.24","OB_score": "NA","CAS_id": "26905-68-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9084","PubChem_id": "NA","DrugBank_id": "NA"}
2-(buta-1,3-diynyl)-5-(but-3-en-1-ynyl) thiophene
{"Ingredient_id": "HBIN005415","Ingredient_name": "2-(buta-1,3-diynyl)-5-(but-3-en-1-ynyl) thiophene","Alias": "2-buta-1,3-diynyl-5-but-3-en-1-ynylthiophene; 2-(buta-1,3-diynyl)-5-(but-3-en-1-ynyl)thiophene; 2-(1,3-Butadiynyl)-5-(3-butene-1-ynyl)thiophene; AC1NST6R","Ingredient_formula": "C12H6S","Ingredient_Smile": "C=CC#CC1=CC=C(S1)C#CC#C","Ingredient_weight": "182.24 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14522","TCMID_id": "2775","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5315560","DrugBank_id": "NA"}